Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 1 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 01, 2022 Filed Apr 4, 2022 22:13 UTC |
Mily ElizabethEVP, Strategy & BD
|
Tax withholdingCommon Stock, $0.10 par value | 2,194 | $73.82 | $161,961.08 |
DisclosureSEC source: 0000014272-22-000103 · wf-form4_164911038576988.xml · nonDerivative · entry 3 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,796 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 22:13 UTC |
Mily ElizabethEVP, Strategy & BD
|
OtherCommon Stock, $0.10 par value | 1,508 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000103 · wf-form4_164911038576988.xml · nonDerivative · entry 2 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,990 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| April 01, 2022 Filed Apr 4, 2022 22:13 UTC |
Mily ElizabethEVP, Strategy & BD
|
Exercise / conversionCommon Stock, $0.10 par value | 3,662 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000103 · wf-form4_164911038576988.xml · nonDerivative · entry 1 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,482 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on April 1, 2020. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:13 UTC |
Rice Derica WDirector
|
GrantDeferred Share Units · Derivative | 496.371 | $73.03 | $36,249.97 |
DisclosureSEC source: 0000014272-22-000104 · wf-form4_164911040458205.xml · derivative · entry 1 Rice Derica W · CIK 0001359067 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,858.921 Underlying: Common Stock, $0.10 par value · 496.371 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:14 UTC |
Arduini Peter JDirector
|
GrantDeferred Share Units · Derivative | 462.139 | $73.03 | $33,750.01 |
DisclosureSEC source: 0000014272-22-000105 · wf-form4_164911043169891.xml · derivative · entry 1 Arduini Peter J · CIK 0001323134 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,266.108 Underlying: Common Stock, $0.10 par value · 462.139 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:14 UTC |
Haller Julia ADirector
|
GrantDeferred Share Units · Derivative | 462.139 | $73.03 | $33,750.01 |
DisclosureSEC source: 0000014272-22-000106 · wf-form4_164911044680593.xml · derivative · entry 1 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,107.698 Underlying: Common Stock, $0.10 par value · 462.139 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:14 UTC |
YALE PHYLLIS RDirector
|
GrantDeferred Share Units · Derivative | 462.139 | $73.03 | $33,750.01 |
DisclosureSEC source: 0000014272-22-000107 · wf-form4_164911046730746.xml · derivative · entry 1 YALE PHYLLIS R · CIK 0001269070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,855.158 Underlying: Common Stock, $0.10 par value · 462.139 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:15 UTC |
Hidalgo Medina ManuelDirector
|
GrantDeferred Share Units · Derivative | 102.698 | $73.03 | $7,500.03 |
DisclosureSEC source: 0000014272-22-000108 · wf-form4_164911049423449.xml · derivative · entry 1 Hidalgo Medina Manuel · CIK 0001865525 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,452.829 Underlying: Common Stock, $0.10 par value · 102.698 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:15 UTC |
Storch Gerald LDirector
|
GrantDeferred Share Units · Derivative | 496.371 | $73.03 | $36,249.97 |
DisclosureSEC source: 0000014272-22-000109 · wf-form4_164911051348905.xml · derivative · entry 1 Storch Gerald L · CIK 0001205004 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,009.312 Underlying: Common Stock, $0.10 par value · 496.371 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 31, 2022 Filed Apr 4, 2022 22:15 UTC |
Samuels Theodore R. IIDirector
|
GrantDeferred Share Units · Derivative | 667.534 | $73.03 | $48,750.01 |
DisclosureSEC source: 0000014272-22-000110 · wf-form4_164911053911290.xml · derivative · entry 1 Samuels Theodore R. II · CIK 0001688276 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,923.33 Underlying: Common Stock, $0.10 par value · 667.534 shares Expires not disclosed F1 · derivative.exercise_price: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.exercise_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F1 · derivative.expiration_date: Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. F2 · balance_after: Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. Read SEC document |
| March 22, 2022 Filed Mar 23, 2022 23:43 UTC |
Caforio GiovanniDirector · Board Chair and CEO
|
GiftCommon Stock, $0.10 par value | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000092 · wf-form4_164807896539251.xml · nonDerivative · entry 2 Caforio Giovanni · CIK 0001533201 · Director · Board Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,104.333 F2 · shares: This transaction involved a donation of securities by the Reporting Person to a charitable organization. Read SEC document |
| March 21, 2022 Filed Mar 23, 2022 23:43 UTC |
Caforio GiovanniDirector · Board Chair and CEO
|
SaleCommon Stock, $0.10 par value | 25,000 | $71.52 | $1,788,000.00 |
DisclosureSEC source: 0000014272-22-000092 · wf-form4_164807896539251.xml · nonDerivative · entry 1 Caforio Giovanni · CIK 0001533201 · Director · Board Chair and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 581,524.333 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 11, 2021. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 8,490 | $0.00 Strike: $38.41 | $0.00 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · derivative · entry 11 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,491 Underlying: Common Stock, $0.10 par value · 8,490 shares Expires 2028-10-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 5,294 | $0.00 Strike: $55.52 | $0.00 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · derivative · entry 10 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 5,294 shares Expires 2028-01-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 12,233 | $0.00 Strike: $54.29 | $0.00 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · derivative · entry 9 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 12,233 shares Expires 2027-10-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionOption (right to buy) · Derivative | 21,288 | $0.00 Strike: $66.35 | $0.00 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · derivative · entry 8 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $0.10 par value · 21,288 shares Expires 2027-05-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: All of the shares are currently exercisable. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
SaleCommon Stock, $0.10 par value | 43,228 | $69.23 | $2,992,674.44 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · nonDerivative · entry 6 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,385 F2 · shares: 43,228 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.16 to $69.33, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F2 · price: 43,228 of the shares sold were to cover the exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions. The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.16 to $69.33, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 8,490 | $38.41 | $326,100.90 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · nonDerivative · entry 5 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 12,233 | $54.29 | $664,129.57 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · nonDerivative · entry 4 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,123 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 5,294 | $55.52 | $293,922.88 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · nonDerivative · entry 3 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,890 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 21,288 | $66.35 | $1,412,458.80 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · nonDerivative · entry 2 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,596 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 16, 2022 Filed Mar 18, 2022 21:50 UTC |
Vessey RupertEVP, Research & Early Dev.
|
SaleCommon Stock, $0.10 par value | 31,331 | $69.27 | $2,170,298.37 |
DisclosureSEC source: 0000014272-22-000090 · wf-form4_164764023320954.xml · nonDerivative · entry 1 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,308 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.26 to $69.305, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.26 to $69.305, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 23:32 UTC |
BOERNER CHRISTOPHER S.EVP, Chief Commercial Officer
|
SaleCommon Stock, $0.10 par value | 29,532 | $69.20 | $2,043,525.80 |
DisclosureSEC source: 0000014272-22-000087 · wf-form4_164747351775482.xml · nonDerivative · entry 1 BOERNER CHRISTOPHER S. · CIK 0001543747 · EVP, Chief Commercial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,966 F1 · shares: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.18 to $69.225, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. F1 · price: The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $69.18 to $69.225, inclusive. The reporting person undertakes to provide the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price. Read SEC document |
| March 14, 2022 Filed Mar 16, 2022 23:32 UTC |
Santiago Karen MurphySVP & Controller
|
SaleCommon Stock, $0.10 par value | 6,577 | $69.20 | $455,095.52 |
DisclosureSEC source: 0000014272-22-000088 · wf-form4_164747353987155.xml · nonDerivative · entry 1 Santiago Karen Murphy · CIK 0001732137 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,704 Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Mily ElizabethEVP, Strategy & BD
|
GrantPerformance Shares · Derivative | 21,952 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000069 · wf-form4_164730695015828.xml · derivative · entry 6 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,952 Underlying: Common Stock, $0.10 par value · 21,952 shares Expires 2025-03-10 F6 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2025. F6 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2025. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Mily ElizabethEVP, Strategy & BD
|
GrantMarket Share Units · Derivative | 14,634 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000069 · wf-form4_164730695015828.xml · derivative · entry 5 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,634 Underlying: Common Stock, $0.10 par value · 14,634 shares Expires 2026-03-10 F4 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F5 · derivative.exercise_date: Twenty-five percent of these market share units will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Mily ElizabethEVP, Strategy & BD
|
Exercise / conversionMarket Share Units · Derivative | 4,005 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000069 · wf-form4_164730695015828.xml · derivative · entry 4 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,017 Underlying: Common Stock, $0.10 par value · 4,005 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Mily ElizabethEVP, Strategy & BD
|
Tax withholdingCommon Stock, $0.10 par value | 1,875 | $68.42 | $128,287.50 |
DisclosureSEC source: 0000014272-22-000069 · wf-form4_164730695015828.xml · nonDerivative · entry 3 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,820 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Mily ElizabethEVP, Strategy & BD
|
OtherCommon Stock, $0.10 par value | 449 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000069 · wf-form4_164730695015828.xml · nonDerivative · entry 2 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,695 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Mily ElizabethEVP, Strategy & BD
|
Exercise / conversionCommon Stock, $0.10 par value | 4,005 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000069 · wf-form4_164730695015828.xml · nonDerivative · entry 1 Mily Elizabeth · CIK 0001808438 · EVP, Strategy & BD 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,246 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
GrantPerformance Shares · Derivative | 42,884 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · derivative · entry 11 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,884 Underlying: Common Stock, $0.10 par value · 42,884 shares Expires 2025-03-10 F8 · derivative.exercise_price: Each performance share converts into one share of common stock upon distribution in the first quarter of 2025. F8 · derivative.exercise_date: Each performance share converts into one share of common stock upon distribution in the first quarter of 2025. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
GrantMarket Share Units · Derivative | 28,589 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · derivative · entry 10 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,589 Underlying: Common Stock, $0.10 par value · 28,589 shares Expires 2026-03-10 F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F7 · derivative.exercise_date: Twenty-five percent of the market share unit award will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionMarket Share Units · Derivative | 7,824 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · derivative · entry 9 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,475 Underlying: Common Stock, $0.10 par value · 7,824 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionMarket Share Units · Derivative | 7,423 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · derivative · entry 8 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,848 Underlying: Common Stock, $0.10 par value · 7,423 shares Expires 2024-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 4,452 | $68.42 | $304,605.84 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · nonDerivative · entry 6 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,639 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
OtherCommon Stock, $0.10 par value | 878 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · nonDerivative · entry 5 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,091 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 7,824 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · nonDerivative · entry 4 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,213 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 4,299 | $68.42 | $294,137.58 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · nonDerivative · entry 3 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,389 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
OtherCommon Stock, $0.10 par value | 981 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · nonDerivative · entry 2 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,688 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:16 UTC |
Vessey RupertEVP, Research & Early Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 7,423 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000070 · wf-form4_164730697074316.xml · nonDerivative · entry 1 VESSEY RUPERT · CIK 0001677618 · EVP, Research & Early Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 76,707 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
GrantPerformance Shares · Derivative | 28,593 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · derivative · entry 10 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,593 Underlying: Common Stock, $0.10 par value · 28,593 shares Expires 2025-03-10 F7 · derivative.exercise_price: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2025. F7 · derivative.exercise_date: Each performance share unit converts into one share of common stock upon distribution in the first quarter of 2025. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
GrantMarket Share Units · Derivative | 19,062 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · derivative · entry 9 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,062 Underlying: Common Stock, $0.10 par value · 19,062 shares Expires 2026-03-10 F5 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F6 · derivative.exercise_date: Twenty-five percent of these market share units will vest on each of the first, second, third and fourth anniversaries of the grant date. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionMarket Share Units · Derivative | 4,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · derivative · entry 8 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,656 Underlying: Common Stock, $0.10 par value · 4,885 shares Expires 2025-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F4 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionMarket Share Units · Derivative | 4,189 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · derivative · entry 7 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,381 Underlying: Common Stock, $0.10 par value · 4,189 shares Expires 2024-03-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each market share unit converts into the number of shares of common stock determined by applying a payout factor to the target number of shares vesting on a given date. The payout factor is a ratio of the average of the closing price on the measurement date plus the nine prior trading days divided by the average stock price on the grant date (also a 10-day average). The minimum payout factor that must be achieved to earn a payout is 60% and the maximum payout factor is 200%. F1 · derivative.exercise_date: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 2,779 | $68.42 | $190,139.18 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · nonDerivative · entry 6 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,722 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
OtherCommon Stock, $0.10 par value | 548 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · nonDerivative · entry 5 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,501 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 4,885 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · nonDerivative · entry 4 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,953 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2021. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Tax withholdingCommon Stock, $0.10 par value | 2,426 | $68.42 | $165,986.92 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · nonDerivative · entry 3 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,068 F3 · shares: Shares withheld for payment of taxes upon vesting of award. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
OtherCommon Stock, $0.10 par value | 553 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · nonDerivative · entry 2 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,494 F2 · shares: Adjustment reflects additional shares acquired upon the vesting of market share units due to the performance factor. Read SEC document |
| March 10, 2022 Filed Mar 15, 2022 01:17 UTC |
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.
|
Exercise / conversionCommon Stock, $0.10 par value | 4,189 | $0.00 | $0.00 |
DisclosureSEC source: 0000014272-22-000072 · wf-form4_164730701224878.xml · nonDerivative · entry 1 Hirawat Samit · CIK 0001781290 · EVP,Chief Med.Offr.,Drug Dev. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,941 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Represents vesting of one-quarter of market share units granted on March 10, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.